losartan has been researched along with Arthropathies in 3 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "Losartan is an angiotensin receptor blocker (ARB) with inhibitory effects on transforming growth factor beta, previously implicated in tissue repair induced fibrosis, and has been studied to prevent stiffness following hip arthroscopy." | 1.91 | The effect of losartan on range of motion and rates of manipulation in total knee arthroplasty: a retrospective matched cohort study. ( Arraut, J; Fiedler, B; Lygrisse, KA; Rozell, JC; Schwarzkopf, R; Singh, V, 2023) |
| "Losartan is an auspicious candidate, as it has demonstrated an antifibrotic effect in other organs." | 1.91 | The effect of losartan on the development of post-traumatic joint stiffness in a rat model. ( Baranowski, A; Drees, P; Gercek, E; Harper, A; Mickan, T; Müller, L; Ritz, U; Rommens, PM; Slotina, E; Truffel, S; Wegner, E; Wunderlich, F, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Arraut, J | 3 |
| Lygrisse, KA | 3 |
| Singh, V | 3 |
| Fiedler, B | 3 |
| Schwarzkopf, R | 3 |
| Rozell, JC | 3 |
| Wegner, E | 1 |
| Mickan, T | 1 |
| Truffel, S | 1 |
| Slotina, E | 1 |
| Müller, L | 1 |
| Wunderlich, F | 1 |
| Harper, A | 1 |
| Ritz, U | 1 |
| Rommens, PM | 1 |
| Gercek, E | 1 |
| Drees, P | 1 |
| Baranowski, A | 1 |
| Piccolo, P | 1 |
| Mithbaokar, P | 1 |
| Sabatino, V | 1 |
| Tolmie, J | 1 |
| Melis, D | 1 |
| Schiaffino, MC | 1 |
| Filocamo, M | 1 |
| Andria, G | 1 |
| Brunetti-Pierri, N | 1 |
3 other studies available for losartan and Arthropathies
| Article | Year |
|---|---|
The effect of losartan on range of motion and rates of manipulation in total knee arthroplasty: a retrospective matched cohort study.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arthroplasty, Replacemen | 2023 |
The effect of losartan on range of motion and rates of manipulation in total knee arthroplasty: a retrospective matched cohort study.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arthroplasty, Replacemen | 2023 |
The effect of losartan on range of motion and rates of manipulation in total knee arthroplasty: a retrospective matched cohort study.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arthroplasty, Replacemen | 2023 |
The effect of losartan on range of motion and rates of manipulation in total knee arthroplasty: a retrospective matched cohort study.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arthroplasty, Replacemen | 2023 |
The effect of losartan on range of motion and rates of manipulation in total knee arthroplasty: a retrospective matched cohort study.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arthroplasty, Replacemen | 2023 |
The effect of losartan on range of motion and rates of manipulation in total knee arthroplasty: a retrospective matched cohort study.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arthroplasty, Replacemen | 2023 |
The effect of losartan on range of motion and rates of manipulation in total knee arthroplasty: a retrospective matched cohort study.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arthroplasty, Replacemen | 2023 |
The effect of losartan on range of motion and rates of manipulation in total knee arthroplasty: a retrospective matched cohort study.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arthroplasty, Replacemen | 2023 |
The effect of losartan on range of motion and rates of manipulation in total knee arthroplasty: a retrospective matched cohort study.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arthroplasty, Replacemen | 2023 |
The effect of losartan on the development of post-traumatic joint stiffness in a rat model.
Topics: Animals; Contracture; Disease Models, Animal; Joint Diseases; Joint Dislocations; Losartan; Rats; Ra | 2023 |
SMAD4 mutations causing Myhre syndrome result in disorganization of extracellular matrix improved by losartan.
Topics: Adolescent; Adult; Child; Cryptorchidism; Extracellular Matrix; Facies; Female; Fibroblasts; Growth | 2014 |